FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/16/2026
Vitae Pharmaceuticals (NASDAQ: VTAE) reported Q1 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).
For earnings history and earnings-related data on Vitae Pharmaceuticals (VTAE) click here.
... More
